Renin-angiotensin system

Recent Advances in IgA Nephropathy

Volumn , Issue , 2009, Pages 289-308

  Neng Lai, Kar ^a   Leung, Joseph C K ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79952042072     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1142/9789812835871_0020     Document Type: Chapter

References (68)

1. GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia). (1997) Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. Lancet 349: 1857-863.
2. Leehey DJ, Singh AK, Alavi N, Singh R. (2000) Role of angiotensin II in diabetic nephropathy. Kidney Int 58(Suppl 77): S93-S98.
3. Ketteler M, Noble NA, Border WA. (1994) Increased expression of transforming growth factor-P in renal disease. Curr Opin Nephrol Hyperten 3: 446-452.
4. Kagami S, Border WA, Miller DE, Noble NA. (1994) Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells. J Clin Invest 93: 2431-2437.
5. Fan JM, Ng YY, Hill PA, et al. (1999) Transforming growth factor-beta regulates tubular epithelial-myofibroblast trans-differentiation in vitro. Kidney Int 56: 1455-1467.
6. Li JH, Zhu HJ, Huang XR, et al. (2002) Smad7 inhibits fibrotic effect of TGF-Beta on renal tubular epithelial cells by blocking Smad2 activation. J Am Soc Nephrol 13: 1464-1472.
7. Bannister KM, Weaver A, Clarkson AR, Woodroffe AJ. (1995) Effect of angiotensin-converting enzyme and calcium channel inhibition on progressive nephropathy. Contrib Nephrol 111: 184-192.
8. Russo D, Minutolo R, Pisani A, et al. (2001) Coadministration of losartan and enalapril exerts additive anti-proteinuric effect in IgA nephropathy. Am J Kidney Dis 38: 18-25.
9. Victor RG. (2007) Pathophysiology of target-organ disease: does angiotensin II remain the key? J Clin Hypertens 9(Suppl 4): 4-10.
10. Lai KN, Leung JC, Lai KB, et al. (1998) Gene expression of the renin- angiotensin system in human kidney. J Hypertens 16: 91-102.
11. Ingelfinger JR, Zuo WM, Fon EA, et al. (1990) In situ hybridization evidence for angiotensinogen messenger RNA in the rat proximal tubule. A hypothesis for the intrarenal renin angiotensin system. J Clin Invest 85: 417-423.
12. Terada Y, Tomita K, Nonoguchi H, Marumo F. (1993) PCR localization of angiotensin II receptor and angiotensinogen mRNAs in rat kidney. Kidney Int 43: 1251-1259.
13. Richoux JP Cordonnier JL, Bouhnik J, et al. (1983) Immunocytochemical localization of angiotensinogen in rat liver and kidney. Cell Tissue Res 233: 439-451.
14. Darby IA, Congiu M, Fernley RT, et al. (1994) Cellular and ultrastructural location of angiotensinogen in rat and sheep kidney. Kidney Int 46: 1557-1560.
15. Darby IA, Sernia C. (1995) In situ hybridization and immunohistochem- istry of renal angiotensinogen in neonatal and adult rat kidneys. Cell Tissue Res 281: 197-206.
16. Kobori H, Harrison-Bernard LM, Navar LG. (2001) Expression of angiotensinogen mRNA and protein in angiotensin II-dependent hypertension. J Am Soc Nephrol 12: 431-439.
17. Yanagawa N, Capparelli AW, Jo OD, et al. (1991) Production of angiotensinogen and renin-like activity by rabbit proximal tubular cells in culture. Kidney Int 39: 938-941.
18. Moe OW, Ujiie K, Star RA, et al. (1993) Renin expression in renal proximal tubule. J Clin Invest 91: 774-779.
19. Henrich WL, McAllister EA, Eskue A, et al. (1996) Renin regulation in cultured proximal tubular cells. Hypertension 27: 1337-1340.
20. Leyssac PE (1986) Changes in single nephron renin release are mediated by tubular fluid flow rate. Kidney Int 30: 332-339.
21. Sibony M, Gasc JM, Soubrier F, et al. (1993) Gene expression and tissue localization of the two isoforms of angiotensin I converting enzyme. Hypertension 21: 827-835.
22. Schulz WW Hagler HK, Buja LM, et al. (1988) Ultrastructural localization of angiotensin I-converting enzyme (EC 3.4.15.1) and neutral metalloen- dopeptidase (EC 3.4.24.11) in the proximal tubule of the human kidney. Lab Invest 59: 789-797.
23. Casarini DE, Boim MA, Stella RC, et al. (1997) Angiotensin I-converting enzyme activity in tubular fluid along the rat nephron. Am J Physio 272: F405-F409.
24. Kobori H, Nangaku M, Navar LG, Nishiyama A. (2007) The intrarenal renin-angiotensin system: from physiology to pathobiology of hypertension and kidney disease. Pharmcol Rev 59: 251-287.
25. Horita Y, Taura K, Taguchi T, et al. (2006) Aldosterone breakthrough during therapy with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in proteinuric patients with IgA nephropathy. Nephrology 11: 462-466.
26. Ischihara A, Kaneshiro Y, Takemitsu T, et al. (2007) The (pro)renin receptor and the kidney. Semin Nephrol 27: 524-528.
27. 2receptor protein in rats with angiotensin-dependent hypertension. Hypertension 33: 96-101.
28. 2receptor subtypes in the rat kidney. Am J Physio 277: F437-F446.
29. Terada Y, Tomita K, Nonoguchi H, Marumo F. (1993) PCR localization of angiotensin II receptor and angiotensinogen mRNAs in rat kidney. Kidney Int 43: 1251-1259.
30. 1receptor in adult rat kidney using a monoclonal antibody. Am J Physiol 273: F170-F177.
31. Lai KN, Chan LY, Tang SC, et al. (2004) Mesangial expression of angiotensin II receptor in IgA nephropathy and its regulation by polymeric IgA1. Kidney Int 66: 1403-1416.
32. Wang L, Flannery PJ, Spurney RF. (2003) Characterization of angiotensin II-receptor subtypes in podocytes. J Lab Clin Med 142: 313-321.
33. Chan LY, Leung JC, Tang SC, et al. (2005) Tubular expression of angiotensin II receptors and their regulation in IgA nephropathy. J Am Soc Nephrol 16: 2306-2317.
34. Bouby N, Hus-Citharel A, Marchetti J, et al. (1997) Expression of type 1 angiotensin II receptor subtypes and angiotensin II-induced calcium mobilization along the rat nephron. J Am Soc Nephrol 8: 1658-1667.
35. Zheng Y, Horita S, Hara C, et al. (2003) Biphasic regulation of renal proximal bicarbonate absorption by luminal AT(1A) receptor. J Am Soc Nephrol 14: 1116-1122.
36. Bhaskaran M, Reddy K, Radhakrishanan N, et al. (2003) Angiotensin II induces apoptosis in renal proximal tubular cells. Am J Physiol Renal Physiol 284: F955-F965.
37. Weikekamm C, Hauser P Hansmann C, et al. (2002) Effect of AT1 and AT2 receptor blockade on angiotensin II induced apoptosis of human renal proximal tubular epithelial cells. Wien Klin Wochenschr 114: 725-729.
38. Caughey GH, Raymond WW, Wolters PJ. (2000) Angiotensin II generation by mast cell alpha- and beta-chymases. Biochim Biophys Acta 1480: 245-257.
39. Okunishi H, Oka Y, Shiota N, et al. (1993) Marked species-difference in the vascular angiotensin II-forming pathways: humans versus rodents. Jpn J Pharmacol 62: 207-210.
40. Yamamoto T, Hayashi K, Matsuda H, et al. (2001) In vivo visualization of angiotensin II and tubuloglomerular feedback-mediated renal vasoconstriction. Kidney Int 60: 364-369.
41. Paul M, Mehr AP, Kreutz R. (2006) Physiology of local renin-angiotensin systems. Physiol Rev 86: 747-803.
42. Lai KN, Chan LY, Leung JC. (2005) Mechanism of tubulointerstitial injury in IgA nephropathy. Kidney Int 94: S110-S115.
43. Miyake-Ogawa C, Miyazaki M, Abe K, et al. (2005) Tissue-specific expression of renin-angiotensin system components in IgA nephropathy. Am J Nephrol 25: 1-12.
44. Kobori H, Katsurada A, Ozawa Y, et al. (2007) Enhanced intrarenal oxidative stress and angiotensinogen in IgA nephropathy patients. Biochem Biophys Res Commun 358: 156-163.
45. Sakamoto-Ihara T, Suzuki Y, Kurusu A, et al. (2007) Possible involvement of mast cells in renal fibrosis in patients with IgA nephropathy. Inflamm Res 56: 421-427.
46. Hale GM, Howarth GS, Aarons I, et al. (1989) Quantitation of glomerular angiotensin II receptors in IgA nephropathy. Clin Nephrol 32: 5-9.
47. Wagner J, Gehlen F, Ciechanowicz A, Ritz E. (1999) Angiotensin II receptor type 1 gene expression in human glomerulonephritis and diabetes mel- litus. J Am Soc Nephrol 10: 545-551.
48. Del Prete D, Gambaro G, Lupo A, et al. (2003) Precocious activation of genes of the renin-angiotensin system and the fibrogenic cascade in IgA glomerulonephritis. Kidney Int 64: 149-159.
49. Makita N, Iwai N, Inagami T, Badr K. (1992) Two distinct pathways in the down-regulation of type-1 angiotensin II receptor gene in rat glomerular mesangial cells. Biochem Biophys Res Commun 185: 142-146.
50. Chansel D, Bizet T, Vandermeersch, et al. (1994) Differential regulation of angiotensin II and losartan binding sites in glomeruli and mesangial cells. Am J Physiol 266: F384-F393.
51. Matsubara H. (1998) Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases. Circ Res 83: 1182-1191.
52. Franco M, Paniagua R, Herrera-Acosta J. (1998) Renal effects of renin- angiotensin system blockade. Curr Opin Nephrol Hypertens 7: 153-158.
53. Cao Z, Bonnet F, Candido R, et al. (2002) Angiotensin type 2 receptor antagonism confers renal protection in a rat model of progressive renal injury. J Am Soc Nephrol 13: 1773-1787.
54. Wolf G. (2002) Angiotensin II and tubular development. Nephrol Dial Transplant 17(Suppl 9): 48-51.
55. Sahajpal V, Ashton N. (2003) Renal function and angiotensin AT1 receptor expression in young rats following intrauterine exposure to a maternal low-protein diet. Clin Sci 106: 607-614.
56. Chan LY, Leung JC, Tsang AW, et al. (2005) Activation of tubular epithelial cells by mesangial-derived TNF-a: glomerulo-tubular communication in IgA nephropathy. Kidney Int 67: 602-612.
57. Berk BC, Corson MA. (1997) Angiotensin II signal transduction in vascular smooth muscle: role of tyrosine kinases. Circ Res 80: 607-616.
58. Gomez-Guerrero C, Duque N, Egido J. (1996) Stimulation of Fc(a) receptors induces tyrosine phosphorylation of phospholipase C-y, phosphatidylinositol phosphate hydrolysis, and calcium mobilization in rat and human mesangial cells. J Immunol 156: 4369-4376.
59. Duque N, Gomez-Guerrero C, Egido J. (1997) Interaction of IgA with Fca receptors of human mesangial cells activates transcription factor nuclear factor-kappa B and induces expression and synthesis, of MCP-1, IL-8, and IFN-inducible protein 10. J Immunol 159: 3474-3482.
60. Diven SC, Caflisch CR, Hammond DK, et al. (1998) IgA induced activation of human mesangial cells: independent of Fc alphaR1 (CD89). Kidney Int 54: 837-847.
61. van den Dobbelsteen ME, van der Woude FJ, Schroeijers WE, et al. (1994) Binding of dimeric and polymeric IgA to rat renal mesangial cells enhances the release of interleukin 6. Kidney Int 46: 512-519.
62. Gomez-Guerrero C, Lopez-Armada MJ, Gonzalez E, Egido J. (1994) Soluble IgA and IgG aggregates are catabolized by cultured rat mesangial cells and induce production of TNF-a and IL-6, and proliferation. J Immunol 153: 5247-5255.
63. Lai KN, Tang SC, Guh JY, et al. (2003) Polymeric IgA1 from patients with IgA nephropathy upregulates transforming growth factor-beta synthesis and signal transduction in human mesangial cells via the renin-angiotensin system. J Am Soc Nephrol 14: 3127-3137.
64. Hunley TE, Julian BA, Phillips JA, et al. (1996) Angiotensin converting enzyme gene polymorphism: potential silencer motif and impact on progression in IgA nephropathy. Kidney Int. 49: 571-577.
65. Woo KT, Lau YK, Choong LH, et al. (2004) Polymorphism of renin- angiotensin system genes in IgA nephropathy. Nephrology 9: 304-309.
66. Tang S, Lai KN. (2001) Gene polymorphism in IgA nephropathy. Nephrology 6: 63-70.
67. Dillon JJ. (2004) Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for IgA nephropathy. Semin Nephrol 24: 218-224.
68. Chan LY, Leung JC, Lai KN. (2004) Novel mechanisms of tubulointerstitial injury in IgA nephropathy: a new therapeutic paradigm in the prevention of progressive renal failure. Clin Exp Nephrol 8: 297-303.